Want to see HK:6618 full AI Analyst Report?
6618 Stock Chart & Stats
HK$37.00
HK$0.78(2.11%)
At close: 4:00 PM EDT
HK$37.00
HK$0.78(2.11%)
Day’s Range― - ―
52-Week RangeHK$31.84 - HK$71.70
Previous CloseN/A
Volume4.55M
Average Volume (3M)7.60M
Market Cap
HK$123.31B
Enterprise ValueHK$51.43K
Total Cash (Recent Filing)HK$47.41B
Total Debt (Recent Filing)HK$874.69M
Price to Earnings (P/E)17.3
Beta1.37
Next Earnings
Mar 29, 2027EPS Estimate
1.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.92
Shares Outstanding3,189,531,000
10 Day Avg. Volume6,883,323
30 Day Avg. Volume7,596,953
Financial Highlights & Ratios
PEG Ratio1.09
Price to Book (P/B)2.65
Price to Sales (P/S)2.17
P/FCF Ratio16.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$65.33Price Target Upside76.57% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)1.86
Revenue Forecast (FY)HK$85.84B
Bulls Say, Bears Say
Bulls Say
Healthy Revenue Growth And Diversified PlatformSustained product growth alongside service revenue gives JD Health multiple expansion engines. A broader platform spanning pharmacy, healthcare services, advertising and insurance payments can support durable customer engagement and reduce reliance on one revenue stream.
Sustained Margin Expansion And Operating EfficiencyNine consecutive quarters of year-over-year margin improvement indicate that profitability gains are becoming embedded rather than purely cyclical. Procurement optimization, scale benefits and disciplined marketing spending can support continued operating leverage.
Very Conservative Balance Sheet And Strong LiquidityMinimal leverage materially lowers refinancing and solvency risk while preserving flexibility for technology investment, partnerships and expansion. The substantial liquidity reserve also gives JD Health resilience if operating conditions or working-capital needs become less favorable.
Bears Say
Free Cash Flow Reset And Uneven Cash ConversionThe reversal in free cash flow weakens financial flexibility despite strong operating cash generation. It may reflect higher investment or working-capital requirements, and persistent divergence between cash flow and earnings could constrain reinvestment or capital returns.
Regulatory And Counterfeit-brand Risks In SupplementsRegulatory scrutiny and counterfeit products can pressure category growth, customer trust and near-term execution. Although stricter standards may benefit legitimate operators over time, JD Health must absorb compliance costs and rebuild momentum in a challenged segment.
AI Monetization Remains UnprovenStrong adoption validates user interest but has not yet demonstrated durable incremental revenue or returns on investment. Continued AI spending could therefore raise execution and monetization risk if conversion, retention and commercial use cases develop slowly.
JD Health International, Inc. News
6618 FAQ
What was JD Health International, Inc.’s price range in the past 12 months?
JD Health International, Inc. lowest stock price was HK$31.84 and its highest was HK$71.70 in the past 12 months.
What is JD Health International, Inc.’s market cap?
JD Health International, Inc.’s market cap is HK$123.31B.
When is JD Health International, Inc.’s upcoming earnings report date?
JD Health International, Inc.’s upcoming earnings report date is Mar 29, 2027 which is in 217 days.
How were JD Health International, Inc.’s earnings last quarter?
JD Health International, Inc. released its earnings results on Aug 13, 2026. The company reported HK$1.248 earnings per share for the quarter, missing the consensus estimate of HK$1.365 by -HK$0.117.
Is JD Health International, Inc. overvalued?
According to Wall Street analysts JD Health International, Inc.’s price is currently Undervalued.
Does JD Health International, Inc. pay dividends?
JD Health International, Inc. does not currently pay dividends.
What is JD Health International, Inc.’s EPS estimate?
JD Health International, Inc.’s EPS estimate is 1.12.
How many shares outstanding does JD Health International, Inc. have?
JD Health International, Inc. has 3,189,531,000 shares outstanding.
What happened to JD Health International, Inc.’s price movement after its last earnings report?
JD Health International, Inc. reported an EPS of HK$1.248 in its last earnings report, missing expectations of HK$1.365. Following the earnings report the stock price went up 1.698%.
Which hedge fund is a major shareholder of JD Health International, Inc.?
Currently, no hedge funds are holding shares in HK:6618
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JD Health International, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$65.33 (76.57% Upside)
HK$65.33 (76.57% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
130.47%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
13.17%
Trailing 12-Months
Company Description
JD Health International, Inc.
JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
6618 Stock 12 Month Forecast
Average Price Target
HK$65.33
▲(76.57% Upside)
Technical Analysis
Kindstar Globalgene Technology, Inc.
―
Jinxin Fertility Group Ltd.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―